Clinical trial
Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de…
NCT00371423 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00371423 |
|---|---|
| Title | Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions |
| Official title | A Multi-center, Single-arm Study of the TAXUS Liberté™-SR Stent for the Direct Stenting Treatment of Patients With de Novo Coronary Artery Lesions |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | TAXUS Liberté™-SR |
| Enrollment | 247 |
| Start date | Mar 1, 2005 |
| Primary completion | Jun 1, 2006 |
| Completion | Sep 1, 2010 |
| First posted | Sep 4, 2006 |
| Last update posted | Feb 2, 2012 |
| Countries | New Zealand, Singapore, Taiwan, United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: